Mineralys Therapeutics Announces JAMA Publication of Full Target-HTN Phase 2 Trial Results for Lorundrostat in Uncontrolled and Treatment-Resistant Hypertension

RADNOR, Pa., Sept. 10, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other diseases driven by abnormally elevated aldosterone, today announced that full results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and treatment-resistant hypertension (rHTN) were published in the Journal of the American Medical Association (JAMA)

Read More
Matt Paulmineralys
PlayMetrics Partners With Blue Star Innovation Partners to Propel Growth

MORRISVILLE, N.C., August 23, 2023 (Newswire.com) - PlayMetrics, a leading provider of operations management software for youth sports organizations, today announced a partnership with Blue Star Innovation Partners ("BSIP"). The growth-focused investment firm, founded by serial entrepreneur Rob Wechsler and backed by Dallas Cowboys owner Jerry Jones, will take a significant ownership position in PlayMetrics. 

Read More
Matt Paulplaymetrics
Joe Lefkoff 1935-2023

This week we said goodbye to our favorite Southern Jew in the Mountain West and most subtly voracious eater of life, Joe Lefkoff. Joe loved people and things so fiercely and yet so quietly: he loved a fluffy matzah ball, Moe’s BBQ, and spending hours moving between the hot tub and the swimming pool reading and sunning. He loved John Le Carre, Stephen Sondheim, Scrabble, and a well-crafted dirty joke. He loved grilling the perfect steak, going to New York and London every year to see the new theater, and chasing a royal straight flush on poker nights with his favorite guys.

Read More
Matt Paul
CU’s Marvin Caruthers awarded inaugural prize, $400K, for biotech work

Marvin Caruthers, a prestigious University of Colorado Boulder biotechnology professor and researcher, has been named the first winner of the Richard N. Merkin Prize in Biomedical Technology for his work in DNA synthesis. The award, which comes with a $400,000 prize, was created by the Merkin Family Foundation and is administered by the Broad Institute of the Massachusetts Institute of Technology and Harvard University.

Read More
Matt Paul
Accenture Takes Stake In Generative AI Enabler Stardog

Global solution provider Accenture Wednesday unveiled an investment in Stardog, a developer of technology that develops knowledge graphs of data that can be used by generative AI for detailed searches.

Stardog is the developer of Stardog Enterprise Knowledge Graphs, a technology that combines data from multiple sources and makes it machine-understandable without changing the underlying data. The aim is to allow such data to be easily searched, and it is being touted as a way to improve searches using generative AI.

Read More
Matt Paulstardog
Thomas Marr Obituary

Thomas George Marr was born May 19, 1952 in Saginaw, Michigan to George and Marie Marr. He died May 3, 2023 in Longmont, Colorado.

He had honorable professional appointments, including Senior Scientist at Los Alamos National Laboratory in the Theoretical Biology Department, and Cold Spring Harbor, where he was Senior Scientist and founder of the Computational Biology Department. Tom had the gift of curiosity and an appetite for life.

Read More
Matt Paul
Summit Ridge Energy and Black Bear Energy announce 17 MW of Solar Installations in MD

Summit Ridge Energy and Black Bear Energy are proud to announce that construction has commenced on four industrial solar projects in Maryland. The sites, in Belcamp and Rosedale, total over 17 MW of rooftop hosted solar that will be part of the Maryland Community Solar program providing low-cost renewable energy to local residents. Developed and owned by Summit Ridge Energy (SRE) and facilitated by Black Bear Energy, these sites will generate over 30 million kWh of electricity annually – the equivalent of powering over 2,000 homes.

Read More
ClinOne Closes Series A Funding Round to Scale its Site and Participant Engagement Platform, Data Driven Insights and Interoperability

ClinOne, the leading provider of Adaptive Experiences in clinical trials announced today it closed a $3 million Series A funding to accelerate the growth of its platform and broaden its reach to serve customers. This latest round, led by Boulder Ventures, with participation from existing investors CU Healthcare Innovation Fund and First Trust Capital Partners, will continue to advance ClinOne’s mission to offer flexible engagement solutions for all participants to support their clinical trial journey.

Read More
Matt Paulclinone